This announcement is a separate document:
Telix Pharmaceuticals Ltd: BLA Filing Update for Renal Cancer Imaging Agent TLX250-CDx
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.